Douglas R. Carlson

Insider Reports History

Location: Canton, MA
Owner filing signature: /s/ Douglas Carlson
Transaction evidence: Report rows are grouped by the transaction date disclosed in the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Douglas R. Carlson

Form 4 holding Chief Financial Officer

Avalyn Pharma Inc.

Security class: Stock Option (Right to Buy)
Shares / value: 211,975
Estimated value
Report date: 30 Apr 2026
Price
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Insider Reports Filed by Douglas R. Carlson

4 AVLN

Avalyn Pharma Inc.

Report period: 29 Apr 2026
Transactions: 1
Transaction value: $0
Accepted by SEC: 01 May 2026, 18:27
Role: Chief Financial Officer
Next action: Open filing details

3 AVLN

Avalyn Pharma Inc.

Report period: 29 Apr 2026
Transactions: 0
Transaction value: $0
Accepted by SEC: 29 Apr 2026, 18:25
Role: Chief Financial and Business Officer Exhibit 24 - Power of Attorney
Next action: Open filing details

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .